Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-015481

Chief Executive Officer acquired 114,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kauffman Michael · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-25 Grant or award : show line 1 in the form +57,200 718,826 D
2021-02-25 Grant or award : show line 2 in the form +57,200 920,152 I

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-25 Grant or award : show line 3 in the form Stock Option (right to buy) +153,500 $14.56 2031-02-24 153,500 153,500 D
2021-02-25 Grant or award : show line 4 in the form Stock Option (right to buy) +153,500 $14.56 2031-02-24 153,500 153,500 I
Loading xslF345X03/doc4.xml…